Related Experiment Video
Updated: May 16, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
[Calciphylaxis: an enigma to the nephrologist]
Vincenzo Barbera1, Luca Di Lullo, Giovanni Otranto
1U.O.C. Nefrologia e Dialisi, Roma, Italy. v.barbera@tin.it
Insights
Calcific uremic arteriopathy (CUA), or calciphylaxis, is a severe condition in dialysis patients with painful skin ulcers and high mortality. This review examines recent findings on CUA pathogenesis, diagnosis, and treatment.
Area of Science:
- Nephrology
- Dermatology
- Vascular Medicine
Background:
- Calcific uremic arteriopathy (CUA), also known as calciphylaxis, is a rare but severe complication in patients with chronic kidney disease.
- Affecting 1-4% of the dialysis population, CUA presents with painful, necrotic skin lesions and has a high mortality rate (60-80%).
- The exact pathogenesis remains unclear, complicating treatment strategies which are often empirical.
Purpose of the Study:
- To systematically review recent advancements in understanding the pathogenesis of CUA.
- To summarize current diagnostic approaches for calcific uremic arteriopathy.
- To review and discuss contemporary treatment options for CUA.
Main Methods:
- Systematic literature review of recent findings on CUA.
- Analysis of studies focusing on pathogenesis, diagnosis, and treatment.
- Synthesis of evidence regarding calcific uremic arteriopathy management.
Main Results:
- Recent research has proposed several pathogenetic hypotheses for CUA.
- Diagnosis often relies on clinical presentation and imaging, though biopsy may be used.
- Treatment remains challenging, with various empirical approaches discussed.
Conclusions:
- Further research into CUA pathogenesis is crucial for developing targeted therapies.
- Early diagnosis and multidisciplinary management are essential for improving outcomes in CUA patients.
- Addressing the high mortality and debilitating nature of calcific uremic arteriopathy requires continued investigation into effective treatments.
Abstract:
Calcific uremic arteriopathy (CUA), also known as calciphylaxis, is a rare condition occurring in patients with moderate to severe chronic kidney disease. It is a serious, debilitating and potentially fatal clinical disorder affecting 1-4% of the dialysis population and is associated with a high mortality rate (60-80%). The clinical picture is characterized by painful skin lesions tending to necrotic or gangrenous ulceration ultimately necessitating amputation. Severe infectious complications leading to sepsis and death are frequent. The pathogenesis of CUA is still unknown and several pathogenetic hypotheses have been put forward; this makes its treatment difficult and often empirical. The current paper presents a systematic review of recent findings on the pathogenesis, diagnosis and treatment of CUA.
More Related Videos
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Nephrotic Syndrome III : Nursing Management
Urinary Tract Calculi I: Introduction

